In 2021 and 2022, G7 Finance and Health Ministers committed to expedite implementation of existing antimicrobial resistance (AMR) strategies, to take additional steps to address antibiotic market failure, create economic conditions to preserve the effectiveness of essential existing antibiotics and ensure their access, strengthen AMR research and development (R&D), and bring novel antibacterials to market that address public health needs. An initial progress report was prepared by the Global AMR R&D Hub and WHO for the G7 Finance and Health Ministers in May 2022, with a progress update requested for 2023.
11.08.2026
Global AMR R&D Hub Newsletter – August 2026
In our latest newsletter, we highlight new analysis of global investment in animal health AMR R&D between 2017 and 2026. The findings reveal key trends in funding, research priorities and remaining investment gaps, providing valuable insights to help inform future research, policy and funding decisions.
